Sichuan Hebang Biotechnology Co Ltd

Sichuan Hebang Biotechnology Co Ltd

Basic MaterialsChemicals
  • Price (CNY)1.54
  • Today's Change0.00 / 0.00%
  • Shares traded83.38m
  • 1 Year change-3.14%
  • Beta0.9422
Data delayed at least 15 minutes, as of Oct 18 2019 08:00 BST.
More ▼

Events & Activity

  • 603077:SHH price reached a new 52-week low of 1.52 at 15:28 BST
  • 603077:SHH trading volume exceeds daily average by +133.02%
  • 603077:SHH price moved over +1.27% to 1.59
  • 603077:SHH price falls below 15-day moving average to 1.56 at 15:07 BST
  • 603077:SHH price rises above 15-day moving average to 1.59 at 15:11 BST

Key statistics

On Friday, Sichuan Hebang Biotechnology Co Ltd (603077:SHH) closed at 1.54, 1.32% above its 52-week low of 1.52, set on Oct 17, 2019.
52-week range
1.52Oct 17 20192.34Apr 08 2019
Previous close1.54
Average volume55.33m
Shares outstanding8.83bn
Free float4.63bn
P/E (TTM)35.15
Market cap13.60bn CNY
EPS (TTM)0.0438
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateJun 15 2018
Div pay-dateJun 15 2018
Data delayed at least 15 minutes, as of Oct 18 2019 08:00 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.